Islay Capital Management LLC Invests $67,000 in Patterson Companies, Inc. (NASDAQ:PDCO)

Islay Capital Management LLC acquired a new stake in Patterson Companies, Inc. (NASDAQ:PDCO) during the 4th quarter, according to its most recent disclosure with the SEC. The fund acquired 2,179 shares of the company’s stock, valued at approximately $67,000.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the stock. Vanguard Group Inc. raised its stake in shares of Patterson Companies by 0.5% in the 4th quarter. Vanguard Group Inc. now owns 9,409,915 shares of the company’s stock valued at $290,390,000 after purchasing an additional 47,897 shares during the period. American Century Companies Inc. raised its position in Patterson Companies by 24.1% in the 4th quarter. American Century Companies Inc. now owns 2,711,030 shares of the company’s stock valued at $83,662,000 after buying an additional 527,054 shares during the last quarter. Equity Investment Corp lifted its stake in Patterson Companies by 16.6% in the 4th quarter. Equity Investment Corp now owns 2,028,964 shares of the company’s stock valued at $62,614,000 after acquiring an additional 289,295 shares in the last quarter. Charles Schwab Investment Management Inc. boosted its position in Patterson Companies by 15.8% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 1,799,942 shares of the company’s stock worth $55,546,000 after acquiring an additional 245,376 shares during the last quarter. Finally, Bank of New York Mellon Corp grew its stake in shares of Patterson Companies by 18.0% during the 4th quarter. Bank of New York Mellon Corp now owns 1,455,729 shares of the company’s stock worth $44,924,000 after acquiring an additional 222,005 shares in the last quarter. 85.43% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

PDCO has been the topic of a number of research reports. Leerink Partners reissued a “market perform” rating and issued a $31.35 price objective (up previously from $29.00) on shares of Patterson Companies in a research report on Wednesday, December 11th. StockNews.com began coverage on Patterson Companies in a report on Friday. They issued a “hold” rating for the company. Morgan Stanley upped their target price on Patterson Companies from $27.00 to $31.35 and gave the stock an “equal weight” rating in a report on Tuesday, December 17th. Piper Sandler decreased their price target on Patterson Companies from $26.00 to $24.00 and set a “neutral” rating for the company in a research note on Friday, December 6th. Finally, Robert W. Baird upped their price objective on Patterson Companies from $25.00 to $31.00 and gave the stock a “neutral” rating in a research note on Thursday, December 12th. Eleven analysts have rated the stock with a hold rating and one has assigned a buy rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $26.57.

Patterson Companies Trading Down 0.9 %

Shares of Patterson Companies stock opened at $30.94 on Friday. The company has a market capitalization of $2.74 billion, a price-to-earnings ratio of 18.09, a P/E/G ratio of 2.71 and a beta of 0.73. The business has a fifty day simple moving average of $31.10 and a two-hundred day simple moving average of $26.86. Patterson Companies, Inc. has a 1 year low of $19.45 and a 1 year high of $31.79. The company has a debt-to-equity ratio of 0.34, a current ratio of 1.37 and a quick ratio of 0.76.

Patterson Companies Company Profile

Patterson Companies, Inc engages in the distribution of dental and animal health products in the United States, the United Kingdom, and Canada. The company operates through three segments: Dental, Animal Health, and Corporate segments. The Dental segment offers consumable products, including infection control, restorative materials, and instruments; basic and advanced technology and dental equipment; practice optimization solutions, such as practice management software, e-commerce, revenue cycle management, patient engagement solutions, and clinical and patient education systems.